These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9393874

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy.
    Ramírez de Molina A, Gallego-Ortega D, Sarmentero-Estrada J, Lagares D, Gómez Del Pulgar T, Bandrés E, García-Foncillas J, Lacal JC.
    Int J Biochem Cell Biol; 2008; 40(9):1753-63. PubMed ID: 18296102
    [Abstract] [Full Text] [Related]

  • 24. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
    Rodríguez-González A, Ramírez de Molina A, Benítez-Rajal J, Lacal JC.
    Prog Cell Cycle Res; 2003; 5():191-201. PubMed ID: 14593713
    [Abstract] [Full Text] [Related]

  • 25. Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.
    Martín-Cantalejo Y, Sáez B, Monterde MI, Murillo MT, Braña MF.
    Eur J Med Chem; 2011 Nov; 46(11):5662-7. PubMed ID: 21996467
    [Abstract] [Full Text] [Related]

  • 26. A novel 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazol with antitumoral activity via cell cycle arrest and induction of apoptosis.
    Báñez-Coronel M, Rodríguez-González A, Martín-Cantalejo Y, Sáez B, Soto J, Villa MJ, Braña MF, Lacal JC.
    Int J Oncol; 2004 Oct; 25(4):1097-103. PubMed ID: 15375561
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
    Giehl K, Seidel B, Gierschik P, Adler G, Menke A.
    Oncogene; 2000 Sep 14; 19(39):4531-41. PubMed ID: 11002426
    [Abstract] [Full Text] [Related]

  • 34. Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.
    Conejo-García A, Báñez-Coronel M, Sánchez-Martín RM, Rodríguez-González A, Ramos A, Ramírez de Molina A, Espinosa A, Gallo MA, Campos JM, Lacal JC.
    J Med Chem; 2004 Oct 21; 47(22):5433-40. PubMed ID: 15481981
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 37. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC, Bachrach U.
    Amino Acids; 2002 Jun 01; 22(2):131-43. PubMed ID: 12395181
    [Abstract] [Full Text] [Related]

  • 38. Upregulation of phospholipase Cgamma1 activity during EGF-induced proliferation of corneal epithelial cells: effect of phosphoinositide-3 kinase.
    Islam M, Akhtar RA.
    Invest Ophthalmol Vis Sci; 2001 Jun 01; 42(7):1472-8. PubMed ID: 11381049
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Jun 01; 24(6):1369-83. PubMed ID: 15138577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.